Single nucleotide polymorphisms in genes of circulatory homeostasis in surviving pediatric intensive care patients with meningococcal infection

Pediatric Critical Care Medicine

Volumn 9, Issue 5, 2008, Pages 517-523

  Bunker Wiersma, Heleen E ^a   Koopmans, Richard P ^a   Kuipers, Taco W ^a   Knoester, Hennie ^a   Bos, Albert P ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Adducing; Angiotensin converting enzyme; Child; Meningococcal disease; Polymorphisms

Indexed keywords

ALPHA ADDUCIN; ANGIOTENSIN 1 RECEPTOR; APELIN RECEPTOR; ARGININE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CYSTEINE; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; GLUTAMINE; GLYCINE; HYDROCORTISONE; INOTROPIC AGENT; SERINE; TRYPTOPHAN; ADDUCIN; CALMODULIN BINDING PROTEIN;

ALLELE; ARTICLE; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DETERMINATION; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HEMODYNAMICS; HOMEOSTASIS; HOMOZYGOTE; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INDEL MUTATION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENINGOCOCCEMIA; MENINGOCOCCOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; ADULT; CASE CONTROL STUDY; GENETICS; INFANT; INTENSIVE CARE UNIT; MIDDLE AGED; MORTALITY;

ADULT; CALMODULIN-BINDING PROTEINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENOTYPE; HOMEOSTASIS; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-1; RETROSPECTIVE STUDIES;

EID: 60849088006     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e318184985b     Document Type: Article

References (33)

1. Pathan N, Faust SN, Levin M: Pathophysiol-ogy of meningococcal meningitis and septi-caemia. Arch Dis Child 2003; 88:601-607
2. de Kleijn ED, Hazelzet JA, Kornelisse RF, et al: Pathophysiology of meningococcal sepsis in children. Eur J Pediatr 1998; 157: 869-880
3. Kriz P, Bobak M, Kriz B: Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: A population based case-control study. Arch Dis Child 2000; 83:117-121
4. Emonts M, Hazelzet JA, de Groot R, et al: Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 2003; 3:565-577
5. Read RC, Cannings C, Naylor SC, et al: Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist in-fluence the severity of meningococcal disease. Ann Intern Med 2003; 138:534-541
6. Hermans PW, Hibberd ML, Booy R, et al: 4G/5G promoter polymorphism in the plas-minogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Lancet 1999; 354:556-560
7. Hibberd ML, Sumiya M, Summerfield JA, et al: Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 1999; 353: 1049-1053
8. Small KM, McGraw DW, Liggett SB: Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 2003; 43:381-411
9. Humma LM, Puckett BJ, Richardson HE, et al: Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 2001; 88:1034-1037
10. Maqbool A, Hall AS, Ball SG, et al: Common polymorphisms of beta1-adrenoceptor: Iden-tification and rapid screening assay. Lancet 1999; 353:897
11. Liggett SB: Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology 2000; 61:167-173
12. Mason DA, Moore JD, Green SA, et al: A gain-of-function polymorphism in a G-protein coupling domain of the human be-ta1-adrenergic receptor. J Biol Chem 1999; 274:12670-12674
13. Green SA, Turki J, Innis M, et al: Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33:9414-9419
14. Eisenach JH, Barnes SA, Pike TL, et al: Arg16/Gly {beta}2-adrenergic receptor polymorphism alters the cardiac output response to isometric exercise. J Appl Physiol 2005; 99:1776-1781
15. Dishy V, Sofowora GG, Xie HG, et al: The effect of common polymorphisms of the be-ta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001; 345:1030-1035
16. Lanfear DE, Jones PG, Marsh S, et al: Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 2005; 294:1526-1533
17. Bianchi G, Ferrari P, Staessen JA: Adducin polymorphism: Detection and impact on hypertension and related disorders. Hypertension 2005; 45:331-340
18. Rigat B, Hubert C, Henc-Gelas F, et al: An insertion/deletion polymorphism in the angio-tensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346
19. Danser AHJ, Schalekamp MADH, Bax WA, et al: Angiotensin-converting enzyme in the human heart: Effect of the deletion/insertion polymorphism. Circulation 1995; 92:1387-1388
20. Harding D, Baines PB, Brull D, et al: Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/ deletion polymorphism. Am J Respir Crit Care Med 2002; 165:1103-1106
21. Bonnardeaux A, Davies E, Jeunemaitre X, et al: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24:63-69
22. Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1110-1116
23. Pollack MM, Patel KM, Ruttimann UE: PRISM III: An updated pediatric risk of mortality score. Crit Care Med 1996; 24:743-752
24. Ferrandi M, Salardi S, Tripodi G, et al: Evidence for an interaction between adducin and Na( )-K( )-ATPase: Relation to genetic hypertension. Am J Physiol 1999; 277(4 Pt 2): H1338-H1349
25. Bianchi G: Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: From gene polymorphism to clinical symptoms. Am J Physiol Regul In-tegr Comp Physiol 2005; 289:R1536-R1549
26. Barlassina C, Schork NJ, Manunta P, et al: Synergistic effect of alpha-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int 2000; 57:1083-1090
27. Cusi D, Barlassina C, Azzani T, et al: Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349:1353-1357
28. Grant FD, Romero JR, Jeunemaitre X, et al: Low-renin hypertension, altered sodium ho-meostasis, and an alpha-adducin polymorphism. Hypertension 2002; 39:191-196
29. Williams GH, Hollenberg NK, Brown C, et al: Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man. J Clin Endo-crinol Metab 1978; 47:725-731
30. Lichtarowicz-Krynska EJ, Cole TJ, Camacho-Hubner C, et al: Circulating aldosterone levels are unexpectedly low in children with acute meningococcal disease. J Clin Endocrinol Metab 2004; 89:1410-1414
31. Zipser RD, Davenport MW, Martin KL, et al: Hyperreninemic hypoaldosteronism in the critically ill: A new entity. J Clin Endocrinol Metab 1981; 53:867-873
32. de Kleijn ED, Joosten KF, van Rijn B, et al: Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease. Pediatr Infect Dis J 2002; 21:330-336
33. den Brinker M, Joosten KFM, Liem O, et al: Adrenal insufficiency in meningococcal sepsis: Bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 2005; 90: 5110-5117